ME Therapeutics Holdings Inc. (CSE:METX)

ME Therapeutics Holdings Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	1.65	1.5	0.65	0.08	0.07	0.05
Cash & Short-Term Investments	1.71	1.5	0.65	0.08	0.07	0.05
Cash Growth	3.30%	131.28%	736.35%	5.91%	47.00%	-
Other Receivables	0.03	0.02	0.01	0.02	0	0.02
Receivables	0.03	0.02	0.01	0.02	0	0.02
Prepaid Expenses	0.03	0.03	0.02	0	-	-
Total Current Assets	1.77	1.54	0.67	0.1	0.08	0.07
Property, Plant & Equipment	0.23	0	0	0	0	0
Other Intangible Assets	0	0	0	0	0	0
Total Assets	2.01	1.54	0.67	0.1	0.08	0.07
Accounts Payable	0.05	0.05	0.11	0.02	0.03	0
Short-Term Debt	-	-	-	0.13	-	-
Current Portion of Long-Term Debt	-	-	0.04	-	-	-
Other Current Liabilities	0.01	0.02	0	0.02	0.01	0
Total Current Liabilities	0.15	0.06	0.15	0.17	0.03	0.01
Long-Term Debt	-	-	-	0.06	0.06	0.04
Total Liabilities	0.17	0.06	0.15	0.23	0.09	0.05
Common Stock	8.59	6.11	4.52	0.51	0.51	0.51
Retained Earnings	-9.39	-8.54	-7.24	-0.72	-0.57	-0.5
Comprehensive Income & Other	2.64	3.9	3.24	0.08	0.04	0.02
Shareholders' Equity	1.84	1.48	0.52	-0.13	-0.02	0.02
Total Liabilities & Equity	2.01	1.54	0.67	0.1	0.08	0.07
Total Debt	0.09	-	0.04	0.19	0.06	0.04
Net Cash (Debt)	1.62	1.5	0.61	-0.12	0.01	0.01
Net Cash Growth	-1.85%	146.52%	-	-	34.62%	-
Net Cash Per Share	0.06	0.06	0.04	-0.01	0.00	0.00
Filing Date Shares Outstanding	29.59	25.19	23.56	6.08	6.08	6.08
Total Common Shares Outstanding	29.59	25.19	23.56	6.08	6.08	6.08
Working Capital	1.63	1.48	0.52	-0.07	0.04	0.06
Book Value Per Share	0.06	0.06	0.02	-0.02	-0.00	0.00
Tangible Book Value	1.84	1.48	0.52	-0.13	-0.02	0.02
Tangible Book Value Per Share	0.06	0.06	0.02	-0.02	-0.00	0.00
Machinery	0.15	0	0	0	0	0

Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.